Annual EBITDA:
-$86.70M+$156.41M(+64.34%)Summary
- As of today, NKTR annual EBITDA is -$86.70 million, with the most recent change of +$156.41 million (+64.34%) on December 31, 2024.
- During the last 3 years, NKTR annual EBITDA has risen by +$375.12 million (+81.23%).
- NKTR annual EBITDA is now -111.77% below its all-time high of $736.37 million, reached on December 31, 2018.
Performance
NKTR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$31.34M+$4.23M(+11.90%)Summary
- As of today, NKTR quarterly EBITDA is -$31.34 million, with the most recent change of +$4.23 million (+11.90%) on September 30, 2025.
- Over the past year, NKTR quarterly EBITDA has increased by +$1.97 million (+5.91%).
- NKTR quarterly EBITDA is now -103.21% below its all-time high of $976.17 million, reached on June 30, 2018.
Performance
NKTR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$135.19M+$1.97M(+1.44%)Summary
- As of today, NKTR TTM EBITDA is -$135.19 million, with the most recent change of +$1.97 million (+1.44%) on September 30, 2025.
- Over the past year, NKTR TTM EBITDA has dropped by -$5.01 million (-3.85%).
- NKTR TTM EBITDA is now -114.08% below its all-time high of $959.86 million, reached on June 30, 2018.
Performance
NKTR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NKTR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +64.3% | +5.9% | -3.9% |
| 3Y3 Years | +81.2% | +9.9% | +55.0% |
| 5Y5 Years | +77.2% | +68.6% | +63.1% |
NKTR EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +81.2% | -28.7% | +28.7% | -7.7% | +55.0% |
| 5Y | 5-Year | at high | +81.2% | -28.7% | +71.9% | -7.7% | +69.2% |
| All-Time | All-Time | -111.8% | +81.2% | -103.2% | +73.4% | -114.1% | +69.2% |
NKTR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$31.34M(+11.9%) | -$135.19M(+1.4%) |
| Jun 2025 | - | -$35.57M(+19.1%) | -$137.16M(-0.4%) |
| Mar 2025 | - | -$43.94M(-80.5%) | -$136.62M(-8.8%) |
| Dec 2024 | -$86.70M(+64.3%) | -$24.35M(+26.9%) | -$125.53M(+3.6%) |
| Sep 2024 | - | -$33.31M(+4.9%) | -$130.19M(-1.2%) |
| Jun 2024 | - | -$35.03M(-6.6%) | -$128.69M(-2.5%) |
| Mar 2024 | - | -$32.84M(-13.2%) | -$125.54M(+1.5%) |
| Dec 2023 | -$243.11M(+24.7%) | -$29.01M(+8.8%) | -$127.41M(+7.0%) |
| Sep 2023 | - | -$31.81M(+0.2%) | -$136.94M(+2.1%) |
| Jun 2023 | - | -$31.88M(+8.2%) | -$139.92M(+7.6%) |
| Mar 2023 | - | -$34.71M(+9.9%) | -$151.40M(+33.6%) |
| Dec 2022 | -$323.04M(+30.1%) | -$38.54M(-10.8%) | -$228.04M(+24.0%) |
| Sep 2022 | - | -$34.79M(+19.7%) | -$300.12M(+20.0%) |
| Jun 2022 | - | -$43.35M(+61.1%) | -$375.30M(+14.4%) |
| Mar 2022 | - | -$111.36M(-0.7%) | -$438.61M(-1.3%) |
| Dec 2021 | -$461.82M(-17.6%) | -$110.62M(-0.6%) | -$433.10M(-0.7%) |
| Sep 2021 | - | -$109.98M(-3.1%) | -$429.96M(-2.4%) |
| Jun 2021 | - | -$106.66M(-0.8%) | -$419.79M(-8.3%) |
| Mar 2021 | - | -$105.85M(+1.5%) | -$387.65M(-6.0%) |
| Dec 2020 | -$392.65M(-3.2%) | -$107.48M(-7.7%) | -$365.74M(+0.2%) |
| Sep 2020 | - | -$99.81M(-33.9%) | -$366.48M(-1.2%) |
| Jun 2020 | - | -$74.52M(+11.2%) | -$361.97M(+8.4%) |
| Mar 2020 | - | -$83.94M(+22.4%) | -$395.37M(+7.8%) |
| Dec 2019 | -$380.54M(-151.7%) | -$108.22M(-13.6%) | -$429.04M(-2.6%) |
| Sep 2019 | - | -$95.29M(+11.7%) | -$418.04M(+0.2%) |
| Jun 2019 | - | -$107.92M(+8.2%) | -$418.70M(-162.9%) |
| Mar 2019 | - | -$117.61M(-21.0%) | $665.39M(-4.8%) |
| Dec 2018 | $736.37M(+1923.6%) | -$97.22M(-1.3%) | $698.80M(-11.6%) |
| Sep 2018 | - | -$95.95M(-109.8%) | $790.63M(-17.6%) |
| Jun 2018 | - | $976.17M(+1259.4%) | $959.86M(+1754.5%) |
| Mar 2018 | - | -$84.20M(-1461.2%) | -$58.01M(-139.5%) |
| Dec 2017 | -$40.38M(+57.5%) | -$5.39M(-107.4%) | -$24.22M(+48.6%) |
| Sep 2017 | - | $73.28M(+275.7%) | -$47.12M(+68.5%) |
| Jun 2017 | - | -$41.70M(+17.3%) | -$149.43M(-5.1%) |
| Mar 2017 | - | -$50.40M(-78.1%) | -$142.14M(-45.8%) |
| Dec 2016 | -$95.12M(-229.0%) | -$28.30M(+2.5%) | -$97.50M(-6.2%) |
| Sep 2016 | - | -$29.03M(+15.6%) | -$91.83M(-55.4%) |
| Jun 2016 | - | -$34.41M(-496.4%) | -$59.10M(+9.5%) |
| Mar 2016 | - | -$5.77M(+74.5%) | -$65.30M(-383.1%) |
| Dec 2015 | -$28.91M(-953.8%) | -$22.62M(-712.1%) | -$13.52M(+46.3%) |
| Sep 2015 | - | $3.69M(+109.1%) | -$25.19M(-146.1%) |
| Jun 2015 | - | -$40.61M(-188.2%) | $54.65M(-27.7%) |
| Mar 2015 | - | $46.02M(+234.2%) | $75.60M(+2224.7%) |
| Dec 2014 | -$2.74M(+97.4%) | -$34.29M(-141.1%) | -$3.56M(-137.3%) |
| Sep 2014 | - | $83.53M(+524.9%) | $9.54M(+112.4%) |
| Jun 2014 | - | -$19.66M(+40.7%) | -$76.92M(+10.8%) |
| Mar 2014 | - | -$33.14M(-56.3%) | -$86.22M(+9.1%) |
| Dec 2013 | -$104.73M(+15.1%) | -$21.20M(-625.1%) | -$94.85M(+16.1%) |
| Sep 2013 | - | -$2.92M(+89.9%) | -$113.12M(+18.9%) |
| Jun 2013 | - | -$28.95M(+30.7%) | -$139.45M(-4.1%) |
| Mar 2013 | - | -$41.78M(-5.8%) | -$134.02M(-7.2%) |
| Dec 2012 | -$123.39M(-14.5%) | -$39.47M(-34.9%) | -$125.02M(-7.4%) |
| Sep 2012 | - | -$29.26M(-24.4%) | -$116.44M(-11.2%) |
| Jun 2012 | - | -$23.52M(+28.3%) | -$104.75M(+6.2%) |
| Mar 2012 | - | -$32.78M(-6.1%) | -$111.70M(-2.5%) |
| Dec 2011 | -$107.79M(-1055.0%) | -$30.89M(-75.9%) | -$108.94M(-32.9%) |
| Sep 2011 | - | -$17.56M(+42.4%) | -$81.96M(-23.3%) |
| Jun 2011 | - | -$30.47M(-1.5%) | -$66.45M(-122.0%) |
| Mar 2011 | - | -$30.01M(-667.3%) | -$29.93M(-3532.3%) |
| Dec 2010 | -$9.33M | -$3.91M(-89.9%) | $872.00K(-71.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$2.06M(-134.0%) | $3.09M(+115.5%) |
| Jun 2010 | - | $6.05M(+665.1%) | -$19.99M(+62.1%) |
| Mar 2010 | - | $791.00K(+146.8%) | -$52.78M(+34.2%) |
| Dec 2009 | -$75.72M(-3082.1%) | -$1.69M(+93.3%) | -$80.25M(+30.6%) |
| Sep 2009 | - | -$25.14M(+6.0%) | -$115.64M(+2.2%) |
| Jun 2009 | - | -$26.74M(-0.2%) | -$118.27M(+0.8%) |
| Mar 2009 | - | -$26.68M(+28.0%) | -$119.22M(+7.2%) |
| Dec 2008 | $2.54M(+135.7%) | -$37.08M(-33.5%) | -$128.51M(-33.2%) |
| Sep 2008 | - | -$27.77M(-0.3%) | -$96.48M(-19.8%) |
| Jun 2008 | - | -$27.69M(+23.0%) | -$80.57M(-21.9%) |
| Mar 2008 | - | -$35.97M(-613.2%) | -$66.08M(-36.2%) |
| Dec 2007 | -$7.12M(+94.3%) | -$5.04M(+57.5%) | -$48.50M(+21.5%) |
| Sep 2007 | - | -$11.86M(+10.2%) | -$61.82M(+0.7%) |
| Jun 2007 | - | -$13.20M(+28.2%) | -$62.29M(+28.0%) |
| Mar 2007 | - | -$18.40M(-0.2%) | -$86.46M(+7.3%) |
| Dec 2006 | -$125.72M(+15.4%) | -$18.36M(-49.0%) | -$93.22M(+9.5%) |
| Sep 2006 | - | -$12.32M(+67.0%) | -$103.04M(+4.8%) |
| Jun 2006 | - | -$37.38M(-48.6%) | -$108.27M(-19.6%) |
| Mar 2006 | - | -$25.16M(+10.7%) | -$90.53M(-6.1%) |
| Dec 2005 | -$148.54M(-171.3%) | -$28.18M(-60.6%) | -$85.34M(-14.4%) |
| Sep 2005 | - | -$17.55M(+10.6%) | -$74.58M(-3.4%) |
| Jun 2005 | - | -$19.64M(+1.7%) | -$72.15M(-3.8%) |
| Mar 2005 | - | -$19.97M(-14.7%) | -$69.49M(-9.1%) |
| Dec 2004 | -$54.76M(-14.6%) | -$17.42M(-15.2%) | -$63.67M(-3.5%) |
| Sep 2004 | - | -$15.12M(+10.9%) | -$61.54M(-8.8%) |
| Jun 2004 | - | -$16.98M(-20.0%) | -$56.55M(-12.8%) |
| Mar 2004 | - | -$14.15M(+7.5%) | -$50.14M(-1.5%) |
| Dec 2003 | -$47.77M(+41.1%) | -$15.29M(-50.9%) | -$49.39M(+12.9%) |
| Sep 2003 | - | -$10.13M(+4.2%) | -$56.67M(+14.7%) |
| Jun 2003 | - | -$10.57M(+21.1%) | -$66.44M(+10.7%) |
| Mar 2003 | - | -$13.40M(+40.6%) | -$74.39M(+7.4%) |
| Dec 2002 | -$81.11M(-15.4%) | -$22.57M(-13.4%) | -$80.33M(+1.5%) |
| Sep 2002 | - | -$19.90M(-7.5%) | -$81.55M(-0.4%) |
| Jun 2002 | - | -$18.52M(+4.3%) | -$81.20M(+3.8%) |
| Mar 2002 | - | -$19.34M(+18.7%) | -$84.36M(+1.0%) |
| Dec 2001 | -$70.32M(-30.9%) | -$23.79M(-21.7%) | -$85.21M(-38.7%) |
| Sep 2001 | - | -$19.55M(+9.8%) | -$61.42M(-46.7%) |
| Jun 2001 | - | -$21.68M(-7.4%) | -$41.87M(-107.4%) |
| Mar 2001 | - | -$20.19M(-251.1%) | -$20.19M(+3.0%) |
| Dec 2000 | -$53.72M(-130.2%) | - | - |
| Dec 1999 | -$23.34M(-26.9%) | - | - |
| Dec 1998 | -$18.39M(-63.0%) | -$5.75M(+0.8%) | -$20.82M(-7.5%) |
| Sep 1998 | - | -$5.80M(-45.3%) | -$19.37M(-13.7%) |
| Jun 1998 | - | -$3.99M(+24.4%) | -$17.03M(-4.9%) |
| Mar 1998 | - | -$5.28M(-22.7%) | -$16.23M(-18.5%) |
| Dec 1997 | -$11.29M(-9.6%) | -$4.30M(-24.1%) | -$13.69M(-3.8%) |
| Sep 1997 | - | -$3.46M(-8.6%) | -$13.20M(-6.1%) |
| Jun 1997 | - | -$3.19M(-16.2%) | -$12.43M(-1.5%) |
| Mar 1997 | - | -$2.74M(+27.8%) | -$12.24M(-5.6%) |
| Dec 1996 | -$10.30M(-33.8%) | -$3.80M(-40.7%) | -$11.60M(-12.6%) |
| Sep 1996 | - | -$2.70M(+10.0%) | -$10.30M(-7.3%) |
| Jun 1996 | - | -$3.00M(-42.9%) | -$9.60M(-11.6%) |
| Mar 1996 | - | -$2.10M(+16.0%) | -$8.60M(+2.3%) |
| Dec 1995 | -$7.70M(-48.1%) | -$2.50M(-25.0%) | -$8.80M(-1.1%) |
| Sep 1995 | - | -$2.00M(0.0%) | -$8.70M(-11.5%) |
| Jun 1995 | - | -$2.00M(+13.0%) | -$7.80M(-13.0%) |
| Mar 1995 | - | -$2.30M(+4.2%) | -$6.90M(-23.2%) |
| Dec 1994 | -$5.20M | -$2.40M(-118.2%) | -$5.60M(-75.0%) |
| Sep 1994 | - | -$1.10M(0.0%) | -$3.20M(-52.4%) |
| Jun 1994 | - | -$1.10M(-10.0%) | -$2.10M(-110.0%) |
| Mar 1994 | - | -$1.00M | -$1.00M |
FAQ
- What is Nektar Therapeutics annual EBITDA?
- What is the all-time high annual EBITDA for Nektar Therapeutics?
- What is Nektar Therapeutics annual EBITDA year-on-year change?
- What is Nektar Therapeutics quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly EBITDA year-on-year change?
- What is Nektar Therapeutics TTM EBITDA?
- What is the all-time high TTM EBITDA for Nektar Therapeutics?
- What is Nektar Therapeutics TTM EBITDA year-on-year change?
What is Nektar Therapeutics annual EBITDA?
The current annual EBITDA of NKTR is -$86.70M
What is the all-time high annual EBITDA for Nektar Therapeutics?
Nektar Therapeutics all-time high annual EBITDA is $736.37M
What is Nektar Therapeutics annual EBITDA year-on-year change?
Over the past year, NKTR annual EBITDA has changed by +$156.41M (+64.34%)
What is Nektar Therapeutics quarterly EBITDA?
The current quarterly EBITDA of NKTR is -$31.34M
What is the all-time high quarterly EBITDA for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly EBITDA is $976.17M
What is Nektar Therapeutics quarterly EBITDA year-on-year change?
Over the past year, NKTR quarterly EBITDA has changed by +$1.97M (+5.91%)
What is Nektar Therapeutics TTM EBITDA?
The current TTM EBITDA of NKTR is -$135.19M
What is the all-time high TTM EBITDA for Nektar Therapeutics?
Nektar Therapeutics all-time high TTM EBITDA is $959.86M
What is Nektar Therapeutics TTM EBITDA year-on-year change?
Over the past year, NKTR TTM EBITDA has changed by -$5.01M (-3.85%)